drugset / Trial / NCT00116064

Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions

NCT00116064

Phase 3 Completed 156 enrolled Kamuzu University of Health Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate intranasal lorazepam in paediatric status epilepticus. This is a potentially, more effective, safer and cheaper treatment for a common paediatric medical emergency compared to our present first line therapy intramuscular paraldehyde.

Timeline

Start
2004-07
Primary completion
Completion
2005-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Lorazepam Small molecule 100 ug/kg Intranasal
Subject paraldehyde Small molecule 0.2 unknown Intramuscular

Indications